Japanese Office REITs Stock News

Astellas Pharma Inc. recently reported full-year results to March 31, 2026, with sales rising to ¥2.14 trillion and net income to ¥291.54 billion, alongside an FDA Priority Review for a broader PADCEV plus Keytruda indication in muscle-invasive bladder cancer. Together with upcoming retinal-disease data presentations and board-level changes under consideration, these developments underscore how oncology and ophthalmology innovation are increasingly central to Astellas’ business mix. We’ll...

SoftBank Group (TSE:9984) is back in focus after outlining Roze, a new AI and robotics venture planned for a high profile U.S. IPO, alongside securing a US$40b loan earmarked for OpenAI investment. See our latest analysis for SoftBank Group. Those Roze and OpenAI moves come after a sharp 50.5% 30 day share price return, helping SoftBank Group reach a ¥5,424 share price, while the 1 year total shareholder return of 193.7% signals strong longer term momentum. If the AI theme around Roze has...

Seiko Epson (TSE:6724) has put out a solidly detailed FY 2026 update, with third quarter revenue at ¥376.5 billion and basic EPS at ¥52.37, while trailing 12 month figures show revenue at about ¥1.38 trillion and EPS at ¥134.84. Over recent periods the company has seen revenue move from ¥339.1 billion in Q4 FY 2025 to ¥376.5 billion in Q3 FY 2026, with quarterly EPS shifting from ¥24.56 to ¥52.37 as net income moved from ¥7,798 million to ¥16,781 million over the same stretch. For investors,...

With inflation pressures, tighter central bank policy and mixed growth signals across major economies, many investors are looking for companies that can keep compounding value without depending on easy money or booming demand. A focus on high return on equity, solid past performance and strong balance sheets can help concentrate on businesses that have already shown they can turn every dollar of capital into meaningful profits while keeping debt in check. This article highlights 3 stocks from...

It's been a mediocre week for CUC Inc. ( TSE:9158 ) shareholders, with the stock dropping 18% to JP¥776 in the week...

It's been a pretty great week for Kandenko Co.,Ltd. ( TSE:1942 ) shareholders, with its shares surging 11% to JP¥6,734...

It's been a pretty great week for NGK Corporation ( TSE:5333 ) shareholders, with its shares surging 16% to JP¥5,121 in...

Sumitomo (TSE:8053) has laid out its FY 2026 scorecard with third quarter revenue of about ¥1.8 trillion and basic EPS of ¥89.49, set against a trailing twelve month revenue base of roughly ¥7.4 trillion and EPS of ¥458.92 that highlight how much earnings power it has put together over the past year. The company has seen quarterly revenue range from around ¥1.75 trillion to ¥1.98 trillion since FY 2025 Q2, while EPS has moved between ¥89.49 and ¥141.26, giving investors a clear view of how...

Asahi Kasei (TSE:3407) has drawn fresh attention after starting a Phase I clinical trial for AK1940, a peptide-based autoimmune drug candidate that management links to its medium-term pharmaceutical growth plans. See our latest analysis for Asahi Kasei. The AK1940 trial and recent bond shelf registration activity come as Asahi Kasei’s share price trades at ¥1,524.5, with a 1-year total shareholder return of 55.53% and 3-year total shareholder return of 75.92%. This suggests momentum has been...

Investors in Tokyo Electron Limited ( TSE:8035 ) had a good week, as its shares rose 3.5% to close at JP¥47,450...

AEON REIT Investment (TSE:3292) has scheduled a board meeting for April 30, 2026, to approve a planned leadership reshuffle at its asset manager, including the appointment of veteran executive Muneaki Yamamoto as director. See our latest analysis for AEON REIT Investment. At a share price of ¥125,400, AEON REIT Investment has seen a 1 day share price return close to flat. Its year to date share price return of a 9% decline contrasts with a 1 year total shareholder return of 3.52%, suggesting...

Toyota Motor has recently outlined plans to build three new vehicle assembly plants in Maharashtra, India, investing about ¥300.00 billion (US$1.90 billion) to lift capacity toward one million units by the 2030s and support exports to the Middle East and Africa, while also partnering with Isuzu to mass-produce a light-duty fuel-cell electric truck using Toyota’s third-generation fuel cell system from fiscal 2027. Together, these moves signal Toyota’s effort to deepen its manufacturing...

Otsuka Corporation ( TSE:4768 ) just released its first-quarter report and things are looking bullish. The company beat...

Last week, you might have seen that West Japan Railway Company ( TSE:9021 ) released its full-year result to the...

The annual results for Heiwa Real Estate Co., Ltd. ( TSE:8803 ) were released last week, making it a good time to...

Shareholders might have noticed that ZOZO, Inc. ( TSE:3092 ) filed its yearly result this time last week. The early...

SBI Holdings (TSE:8473) has put solid numbers on the board for FY 2026 so far, with third quarter revenue of ¥587.1 billion and basic EPS of ¥278.09, alongside trailing twelve month revenue of ¥1.9 trillion and EPS of ¥650.41 that reflect a very large 218.4% earnings increase over the past year and a net profit margin moving from 9.5% to 21.4%. The company has seen revenue lift from ¥337.4 billion in the third quarter of FY 2025 to ¥587.1 billion in the third quarter of FY 2026, while...

DMG Mori (TSE:6141) has entered its Q1 2026 reporting season with recent quarterly numbers that include Q4 2025 revenue of ¥173,645 million and basic EPS of ¥4.51, set against trailing twelve month EPS figures that range from ¥33.68 to ¥153.31 on revenue between ¥524,261 million and ¥550,498 million. The company has seen revenue move from ¥154,190 million in Q4 2024 to ¥173,645 million in Q4 2025, while quarterly EPS shifted from ¥37.77 to ¥4.51 over the same period. This sets up a results...

The investors in TOTO LTD. 's ( TSE:5332 ) will be rubbing their hands together with glee today, after the share price...

As you might know, Lasertec Corporation ( TSE:6920 ) last week released its latest quarterly, and things did not turn...

Nxera Pharma (TSE:4565) has opened Q1 2026 earnings season with Q4 2025 revenue of ¥7.8 billion and a basic EPS loss of ¥85.32, alongside net income excluding extraordinary items of a ¥7.7 billion loss. Over recent quarters, the company has reported revenue between ¥6.6 billion and ¥8.5 billion, while basic EPS has ranged from a loss of ¥8.45 to a loss of ¥85.32 as profitability pressure has persisted. For investors, the focus this quarter is on how that revenue base relates to margins and...

GNI Group Ltd. announced that its consolidated subsidiary, Gyre Pharmaceuticals, has enrolled the first patient in a Phase 2/3 trial of its self-developed pirfenidone capsules (Etuary®) for radiation-induced lung injury with or without immune checkpoint inhibitor-related pneumonitis, following Chinese regulatory approval in March 2025. This step advances pirfenidone into oncology supportive care, targeting a serious complication of thoracic cancer treatment where current therapeutic options...

In April 2026, Otsuka Holdings Co., Ltd. reported first-quarter 2026 results showing sales of ¥630,342 million and net income of ¥98,348 million, both higher than the same period a year earlier, with basic earnings per share from continuing operations rising to ¥186.31. This combination of higher sales, stronger net income, and improved earnings per share suggests the company converted top-line growth into more efficient profitability in the quarter. We’ll now examine how this stronger...

Mitsubishi Corporation has released its full-year results for the period ended March 31, 2026, reporting sales of ¥18.92 trillion and net income of ¥800.46 billion, both slightly higher sales but lower profit than the previous year. The earnings report also showed a reduction in basic earnings per share from continuing operations to ¥210.92, highlighting pressure on profitability despite revenue growth. We’ll now examine how this weaker earnings profile, alongside the planned sale of...